2021 International Congress on Myeloproliferative Neoplasms
A

Hot Topics in Hypereosinophilic Syndrome

By 2021 International Congress on Myeloproliferative Neoplasms FEATURING Amy D. Klion
By 2021 International Congress on Myeloproliferative Neoplasms FEATURING Amy D. Klion
137 views
December 15, 2021
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
21:05
Louisville Hematology Highlights

Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Feat. R. Gale
08:44
American Contact Dermatitis Society (ACDS)

What to Do When Patch Testing is Negative?

Feat. M. Montanez-Wiscovich
21:52
Insights from 2023 ASH Annual Meeting

ASH 2023 Summary: "MF, ET, and PV - Highlights and Clinical Imp…

Feat. D. Tremblay
10:02
Insights from 2023 ASH Annual Meeting

ASH 2023 Summary: "The Best of MPNs - Highlights & Key Take…

Feat. R. Mesa
22:10
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Inpatient Recognition & Management of H…

Feat. A. Zoref-Lorenz
40:21
Fred Hutch 13th Annual Comprehensive Hematology & Oncology Review Course

Overview of Hematopoietic Cell Transplantation

Feat. R. Salit
14:01
XIV Eurasian Hematology-Oncology Congress - EHOC 2023

Pediatric HLH: Terminology and Diagnosis

Feat. E. Yilmaz Keskin
11:39
Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient

2024 Updates in Myeloproliferative Neoplasms

Feat. E. Hexner
17:51
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

Chronic GVHD: A Case-Based Discussion

Feat. L. Perry
08:45
XIV Eurasian Hematology-Oncology Congress - EHOC 2023

A NGS Test for Congenital Neutropenia in Pediatric Patients

Feat. A. Koca Yozgat
27:47
City of Hope

Chronic GVHD: Review Advances in Prevention, Novel Endpoints, and Ta…

Feat. I. Amanam
22:30
Indy Hematology Review

Targets and Treatments of MPNs in 2023

Feat. R. Mesa
23:12
Total Health

West Oncology Conference: Overview and Updates in MPNs

Feat. J. Chandler
09:08
Paul Kaesberg

Itching in PV (and Other MPNs)

08:24
ASH 2022 Conference Coverage

Phase 2 FIGHT-203 Study: Pemigatinib in Pts With Myeloid/Lymphoid Ne…

Feat. A. Vannucchi
17:49
Yale Cancer Center

Yale ASH Highlights - Myeloid Malignancies: Focus on MPNs

Feat. N. Podoltsev
32:39
MyCancerHaven

Experts Discuss the Basics of Allogeneic Stem Cell Transplant

Feat. R. Vij, M. Christopher
16:48
SOHO 2023 Eleventh Annual Meeting

SOHO 2023: Choosing and Properly Using a JAK Inhibitor in Myelofibro…

Feat. A. Hunter
20:06
UChicago Medicine

Updates in MPNs

Feat. A. Patel
06:46
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Guadecitabine in Higher-Risk MDS and CMML U…

Feat. S. Urrutia